SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MGI Pharma MOGN New patents, anti cancer -- Ignore unavailable to you. Want to Upgrade?

To: Russian Bear who wrote (1059)7/14/1998 9:05:00 PM
From: David Cathcart  Respond to of 1826
 
R.B.

Thanks for clarifying the shareholder rights plan. Let's hope that MOGN has something cooking that will make this issue something more than moot.

BTW, I took the plunge and bought some CALLS just before the recent price surge when MOGN was trading at 6 3/4. I bought a small amount of August 7«'s and a few more January 10's. Tomorrow will dictate whether the August bet was fortunate. I have a little more time with January. MOGN is an investment. These CALLS are a crap shoot.

Good luck everyone.

David



To: Russian Bear who wrote (1059)7/15/1998 6:59:00 AM
From: gy  Read Replies (1) | Respond to of 1826
 
David and Russian: Thank you and I like the idea of "shareholder right plan" specially it is likely good for us shareholder. I am expecting (hope) to see a good results from MGI today: 1.earning positive due to increase selling their products 2. developing in MGI114 3. other good news

Go MOGN


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News